Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

Martin J van den Bent, S A Ghisai, Wolfgang Wick, M. Sanson, Alba A. Brandes, Paul Clement, Sara Erridge, Michael A Vogelbaum, Anna Nowak, Jean‐François Baurain, Warren P Mason, Helen Wheeler, Émeline Tabouret, Sanjeev Gill, Matthew Griffin, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C Reijneveld, Roelien H. Enting, Sébastien Tran, Thierry Lesimple, M Kocher, Anja Gijtenbeek, Elizabeth Lim, Ulrich Herrlinger, Peter Hau, F. Dhermain, K. Aldape, Robert B Jenkins, Hendrikus J. Dubbink, J. M. Kros, Pieter Wesseling, Youri Hoogstrate, Sarah Nuyens, Vassilis Golfinopoulos, C Mircea S Tesileanu, Thierry Gorlia, Pim French, Brigitta G. Baumert